tirzepatide vs semaglutide benefits risks Semaglutide vs tirzepatide side effects:

41.5% had a history of MI or stroke

Understanding what to expect helps you distinguish normal adaptation from side effects requiring medical attention

Real-world data show early discontinuation of GLP-1 therapy is linked to higher risks of coronary artery disease and heart failure.

Twenty-pound weight loss on semaglutide typically occurs over 46 months in clinical trials, though individual timelines vary widely based on baseline metabolic factors, adherence, and dose titration

It is supplied in capsule form and is widely studied for its ability to stimulate the endogenous release of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) without directly administering these hormones